199 related articles for article (PubMed ID: 37529677)
1. The G protein-first activation mechanism of opioid receptors by Gi protein and agonists.
Mafi A; Kim SK; Goddard WA
QRB Discov; 2021; 2():e9. PubMed ID: 37529677
[TBL] [Abstract][Full Text] [Related]
2. The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5836-5843. PubMed ID: 32127473
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
[TBL] [Abstract][Full Text] [Related]
4. Biased Activation Mechanism Induced by GPCR Heterodimerization: Observations from μOR/δOR Dimers.
Chen X; Yuan Y; Chen Y; Yu J; Wang J; Chen J; Guo Y; Pu X
J Chem Inf Model; 2022 Nov; 62(22):5581-5600. PubMed ID: 36377848
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
[TBL] [Abstract][Full Text] [Related]
6. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of the Apo µ-Opioid Receptor in Complex with Gi Protein.
Lima MRP; Bezerra RFS; Serafim DDB; Sena Junior DM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686252
[TBL] [Abstract][Full Text] [Related]
8. GDP Release from the Open Conformation of Gα Requires Allosteric Signaling from the Agonist-Bound Human β
Kumar V; Hoag H; Sader S; Scorese N; Liu H; Wu C
J Chem Inf Model; 2020 Aug; 60(8):4064-4075. PubMed ID: 32786510
[TBL] [Abstract][Full Text] [Related]
9. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.
Xu W; Campillo M; Pardo L; Kim de Riel J; Liu-Chen LY
Biochemistry; 2005 Dec; 44(49):16014-25. PubMed ID: 16331961
[TBL] [Abstract][Full Text] [Related]
10. Structures of the entire human opioid receptor family.
Wang Y; Zhuang Y; DiBerto JF; Zhou XE; Schmitz GP; Yuan Q; Jain MK; Liu W; Melcher K; Jiang Y; Roth BL; Xu HE
Cell; 2023 Jan; 186(2):413-427.e17. PubMed ID: 36638794
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.
Morinville A; Cahill CM; Kieffer B; Collier B; Beaudet A
Pain; 2004 Jun; 109(3):266-273. PubMed ID: 15157687
[TBL] [Abstract][Full Text] [Related]
12. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
[TBL] [Abstract][Full Text] [Related]
13. An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.
French AR; van Rijn RM
Pharmacol Res; 2022 Mar; 177():106091. PubMed ID: 35101565
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
[TBL] [Abstract][Full Text] [Related]
15. Analysis of natural product regulation of opioid receptors in the treatment of human disease.
Badal S; Turfus S; Rajnarayanan R; Wilson-Clarke C; Sandiford SL
Pharmacol Ther; 2018 Apr; 184():51-80. PubMed ID: 29097308
[TBL] [Abstract][Full Text] [Related]
16. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.
Rozenfeld R; Devi LA
FASEB J; 2007 Aug; 21(10):2455-65. PubMed ID: 17384143
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.
Breit A; Gagnidze K; Devi LA; Lagacé M; Bouvier M
Mol Pharmacol; 2006 Aug; 70(2):686-96. PubMed ID: 16682504
[TBL] [Abstract][Full Text] [Related]
18. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
[TBL] [Abstract][Full Text] [Related]
19. NMR backbone and methyl resonance assignments of an inhibitory G-alpha subunit in complex with GDP.
Goricanec D; Hagn F
Biomol NMR Assign; 2019 Apr; 13(1):131-137. PubMed ID: 30539422
[TBL] [Abstract][Full Text] [Related]
20. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
Quist E; Satumtira N; Vasan R
Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
